HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab.

AuthorsW I Essayed, A Bernard, M Kalamarides
JournalJournal of neuro-oncology (J Neurooncol) Vol. 125 Issue 2 Pg. 445-6 (Nov 2015) ISSN: 1573-7373 [Electronic] United States
PMID26337624 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Bevacizumab
Topics
  • Adult
  • Angiogenesis Inhibitors (therapeutic use)
  • Bevacizumab (therapeutic use)
  • Ependymoma (complications, diagnostic imaging, drug therapy)
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Neurofibromatosis 2 (complications, drug therapy)
  • Radiography
  • Spinal Cord Neoplasms (complications, diagnostic imaging, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: